Dysis Medical, a UK-based medical devices company to treat cervical cancer formerly known as Forth Photonics, has raised £7.4m ($11.3m) from a consortium including Lundbeckfond Ventures, the quasi-corporate venturing unit of the eponymous Denmark-based foundation that owns large stakes in local healthcare companies.
Lundbeckfond Ventures invested £6m as a new investor with the other investors in the round included venture capital firms Albion Ventures and NBGI and the Scottish Investment Bank (SIB), the investment unit of state-backed Scottish Enterprise.
In…
